Intermediate for Ticagrelor. Ticagrelor(trade name Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor. Ticagrelor is an antagonist of the P2Y12 receptor. Ticagrelor has been approved by US FDA in on July 20, 2011.


Product Name:                  (3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol

Synonyms:                         N/A

CAS Number:                     155899-66-4

Molecular Weight:            173.2114

Molecular Formula:          C8H15NO3

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               N[C@@H]1C[C@@H]([C@@H]2[C@H]1OC(O2)(C)C)O


  • $138.00
  • Ex Tax: $138.00

Available Options